Microwave ablation of the T1a small renal mass: expanding beyond 3 cm.
Jessica QiuChristopher BallantyneClint YeamanMoritz LangeJohn MorganJ Patrick MershonIman RichieAnthony DeNovioMatthew B ClementsTracey L KrupskiNoah SchenkmanJennifer Mason LoboPublished in: Abdominal radiology (New York) (2023)
With comparable oncological outcomes, complication rates, and renal function preservation, MWA is a promising management strategy for renal masses of 3-4 cm in select patients. Our findings suggest that current AUA guidelines, which recommend thermal ablation for tumors < 3 cm, may need review to include T1a tumors for MWA, regardless of size.
Keyphrases
- end stage renal disease
- chronic kidney disease
- radiofrequency ablation
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- patient reported outcomes
- clinical practice
- magnetic resonance
- computed tomography
- adipose tissue
- type diabetes
- atrial fibrillation
- radical prostatectomy
- ultrasound guided
- glycemic control
- fine needle aspiration